Applied Genetic Top Management

AGTCDelisted Stock  USD 0.39  0.00  0.00%   
Applied Genetic employs about 102 people. The company is managed by 36 executives with a total tenure of roughly 274 years, averaging almost 7.0 years of service per executive, having 2.83 employees per reported executive. Evaluation of Applied Genetic's management performance can provide insight into the firm performance.
Susan Washer  CEO
CEO and President and Director
Scott Koenig  Chairman
Chairman of the Board
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Applied Genetic Management Team Effectiveness

The company has return on total asset (ROA) of (0.5) % which means that it has lost $0.5 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6114) %, meaning that it created substantial loss on money invested by shareholders. Applied Genetic's management efficiency ratios could be used to measure how well Applied Genetic manages its routine affairs as well as how well it operates its assets and liabilities.

Applied Genetic Workforce Comparison

Applied Genetic is number one stock in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 167,092. Applied Genetic adds roughly 102 in number of employees claiming only tiny portion of equities under Health Care industry.

Applied Genetic Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied Genetic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied Genetic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Applied Genetic insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Applied Genetic Notable Stakeholders

An Applied Genetic stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Applied Genetic often face trade-offs trying to please all of them. Applied Genetic's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Applied Genetic's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Susan WasherCEO and President and DirectorProfile
Scott KoenigChairman of the BoardProfile
Rabia OzdenVice President - Clinical Research & DevelopmentProfile
Jonathan SparksVice President - Legal AffairsProfile
Stephen PotterVice President Chief Business OfficerProfile
Jeffrey ChulayVice President Chief Medical OfficerProfile
Karen CarrollVice President - Clinical Development OperationsProfile
Lanita ScottVice President - Clinical Research and Medical AffairsProfile
William SullivanCFOProfile
Lawrence BullockCFOProfile
Arnold OronskyIndependent DirectorProfile
Bruce PeacockDirectorProfile
David KnopDirector - Process developmentProfile
Ivana MagovcevicDirectorProfile
James RosenIndependent DirectorProfile
Ellery MangasSenior Director - Regulatory AffairsProfile
Anne VanLentDirectorProfile
Eric OlsonSenior Director - Corporate DevelopmentProfile
Ivana MagovcevicLiebischDirectorProfile
David GuyerDirectorProfile
Edward HurwitzIndependent DirectorProfile
William AliskiDirectorProfile
Gerald ReynoldsPrincipal OfficerProfile
Michael GoldsteinChief Medical OfficerProfile
Theresa HeahChief Medical OfficerProfile
Matthew FeinsodInterim Chief Medical OfficerProfile
Jonathan MBAChief OfficerProfile
William HauswirthCoFounder BoardProfile
Susan MDChief OfficerProfile
Richard SamulskiCoFounderProfile
Abraham ScariaChief OfficerProfile
Terence MDCoFounderProfile
Brian KrexGeneral CounselProfile
Andrew AsheGeneral CounselProfile
Mark ShearmanChief Scientific OfficerProfile
Nicholas MuzyczkaCoFounderProfile

About Applied Genetic Management Performance

The success or failure of an entity such as Applied Genetic often depends on how effective the management is. Applied Genetic management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Applied management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Applied management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company was incorporated in 1999 and is headquartered in Alachua, Florida. Applied Genetic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.
The data published in Applied Genetic's official financial statements usually reflect Applied Genetic's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Applied Genetic. For example, before you start analyzing numbers published by Applied accountants, it's critical to develop an understanding of what Applied Genetic's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Applied Genetic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Applied Genetic's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Applied Genetic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Applied Genetic. Please utilize our Beneish M Score to check the likelihood of Applied Genetic's management manipulating its earnings.

Applied Genetic Workforce Analysis

Traditionally, organizations such as Applied Genetic use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Applied Genetic within its industry.

Applied Genetic Manpower Efficiency

Return on Applied Genetic Manpower

Revenue Per Employee3.2K
Revenue Per Executive9K
Net Loss Per Employee675.9K
Net Loss Per Executive1.9M
Working Capital Per Employee835.4K
Working Capital Per Executive2.4M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Applied Stock

If you are still planning to invest in Applied Genetic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Genetic's history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world